Impact of disease activity and cumulative damage on the health of lupus patients

被引:121
作者
Fortin, PR
Abrahamowicz, M
Neville, C
du Berger, R
Fraenkel, L
Clarke, AE
Danoff, D
机构
[1] Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada
[3] Montreal Gen Hosp, Div Rheumatol, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada
[5] Boston Univ, Med Ctr, Arthrit Ctr, Boston, MA 02215 USA
关键词
health status; physical function; activity; damage;
D O I
10.1191/096120398678919813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To test if lupus activity and damage predict physical function and general health in lupus was the objective of this study. Ninety-six patients with lupus were seen at baseline and monthly for 4 months. Sociodemographic characteristics and lupus damage (SLICC/ACR DI), were collected at baseline while lupus activity (SLAM-R, SLEDAI), health status measures (HAQ, SF-36(TM)) and immunological tests were collected at each visit. Associations of lupus activity and damage with general health and physical function were evaluated. Baseline health status measures were greatly impaired and comparable to those of severe medical illnesses. In cross-sectional analyses, baseline activity score measured by SLAM-R, but not by SLEDAI, correlated with most subscales of SF-36(TM) Baseline damage score SLICC/ACR DI correlated only with the HAQ and the physical function subscale of SF-36(TM). Differences in both activity measures (SLAM-R and SLEDAI) over time correlated with change in health status measures while baseline cumulative damage (SLICC/ACR DI) correlated with the average level of physical function only. Lupus activity measures, SLAM-R and SLEDAI, although differing cross-sectionally, both reflected patients' health status performance over time and lupus damage measure, SLICC/ACR DI, performed well in assessing physical function. Lupus patients scores for health are poor and comparable to those found in severe medical illnesses.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 20 条
  • [1] Abrahamowicz M, 1998, J RHEUMATOL, V25, P277
  • [2] ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
  • [3] NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION
    AKAIKE, H
    [J]. IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) : 716 - 723
  • [4] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [5] FORTIN PR, 1995, J RHEUMATOL, V22, P2078
  • [6] FRIES JF, 1982, J RHEUMATOL, V9, P789
  • [7] GARY NC, 1990, SAS STAT USERS GUIDE, V2
  • [8] GINZLER E, 1987, J RHEUMATOL, V14, P218
  • [9] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369
  • [10] Gladman DD, 1996, CLIN EXP RHEUMATOL, V14, P305